Status:

UNKNOWN

Single-Anastomosis Duodeno-Ileal Bypass With Sleeve Gastrectomy (SADI-S) for the Treatment of Morbid Obesity and Its Metabolic Complications

Lead Sponsor:

Hospital San Carlos, Madrid

Conditions:

Morbid Obesity

Diabetes

Eligibility:

All Genders

18-75 years

Brief Summary

Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy is a modified and simplified duodenal switch. It is performed on morbid obese patients and severe T2DM patients with obesity, and a prop...

Detailed Description

A sleeve gastrectomy over a wide bougie is performed. Then the proximal duodenum is divided and anastomosed to the ileum 250 cm from the cecum. The preoperative studies and postoperative follow up is...

Eligibility Criteria

Inclusion

  • BMI \> 30 with T2DM or BMI \> 40

Exclusion

  • Oncologic patients, alcoholic patients, mentally retarded

Key Trial Info

Start Date :

April 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2015

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT01463904

Start Date

April 1 2007

End Date

April 1 2015

Last Update

November 2 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Clínico San Carlos

Madrid, Madrid, Spain, 28040

Single-Anastomosis Duodeno-Ileal Bypass With Sleeve Gastrectomy (SADI-S) for the Treatment of Morbid Obesity and Its Metabolic Complications | DecenTrialz